Medication info
Dimantin Tablet 5 mg (Memantine Hydrochloride)

Dimantin Tablet 5 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201708542 · Approved 2017.12.22 · Insurance code 642004160

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily for 7 days. Week 3 (Days 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for older patients aged 65 years or older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily at least 7 days after administration, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a neurodegenerative disorder characterized by the gradual decline of memory and cognitive functions, and this drug helps to slow the progression of these symptoms and improve the quality of life for patients.

How to take

Adult dose

This drug is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily for 7 days. Week 3 (Days 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for older patients aged 65 years or older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily at least 7 days after administration, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medication should not be used in patients with allergies to its ingredients or severe liver or kidney dysfunction. Additionally, since it contains lactose, it should not be administered to patients with lactose intolerance or certain genetic digestive disorders. Patients with epilepsy or a history of seizures, as well as those who are prone to seizures should use this medication with caution. Concurrent use with other medications that have similar effects can increase the likelihood of central nervous system side effects, so co-administration should be avoided. Patients who may experience changes in urine acidity (pH) or who have had recent heart-related issues should also exercise caution when using this medication. Potential side effects may include dizziness, headache, constipation, drowsiness, and hypertension, so it is advisable to consult with a healthcare provider if symptoms are severe. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about any current medications you are taking, especially when using specific antipsychotic medications or blood pressure medications. The safety of this medication has not been established in pregnant or nursing women; if you are pregnant or breastfeeding, it is recommended to avoid using this medication or to consult a specialist. The safety and efficacy of this medication have not been confirmed in children or adolescents under 18 years of age. In case of overdose, central nervous system symptoms and gastrointestinal symptoms may occur, and immediate medical attention should be sought. This drug may affect the patient's reaction speed or concentration; special caution is advised when driving or operating machinery. Finally, this medication should be stored out of the reach of children and should not be transferred to other containers to ensure safety.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggression
  • delirium
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This will help to preserve the drug's efficacy and safety for an extended period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.